Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Sanofi ADR (NASDAQ: SNY) closed at $50.15 down -2.30% from its previous closing price of $51.33. In other words, the price has decreased by -$2.30 from its previous closing price. On the day, 1.36 million shares were traded. SNY stock price reached its highest trading level at $50.95 during the session, while it also had its lowest trading level at $50.12.
Ratios:
For a deeper understanding of Sanofi ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.61. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.27. In the meantime, Its Debt-to-Equity ratio is 0.25 whereas as Long-Term Debt/Eq ratio is at 0.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on January 23, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $55.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNY now has a Market Capitalization of 125478313984 and an Enterprise Value of 74114465792. As of this moment, Sanofi’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.59, and their Forward P/E ratio for the next fiscal year is 10.69. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.40. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.70 while its Price-to-Book (P/B) ratio in mrq is 1.53. Its current Enterprise Value per Revenue stands at 1.601 whereas that against EBITDA is 6.075.
Stock Price History:
The Beta on a monthly basis for SNY is 0.57, which has changed by -0.04466778 over the last 52 weeks, in comparison to a change of 0.23279357 over the same period for the S&P500. Over the past 52 weeks, SNY has reached a high of $55.72, while it has fallen to a 52-week low of $42.63. The 50-Day Moving Average of the stock is 2.43%, while the 200-Day Moving Average is calculated to be 2.74%.
Shares Statistics:
For the past three months, SNY has traded an average of 2.48M shares per day and 2581190 over the past ten days. A total of 2.51B shares are outstanding, with a floating share count of 2.51B. Insiders hold about 0.00% of the company’s shares, while institutions hold 10.31% stake in the company. Shares short for SNY as of 1719532800 were 8067561 with a Short Ratio of 3.25, compared to 1717113600 on 5164928.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 3.71.
